| Determination of risk factors for drug-related problems: a multidisciplinary triangulation process CP Kaufmann, D Stämpfli, KE Hersberger, ML Lampert BMJ open 5 (3), e006376, 2015 | 167 | 2015 |
| Evaluation of drug‐related problems and subsequent clinical pharmacists’ interventions at a Swiss university hospital D Reinau, C Furrer, D Stämpfli, D Bornand, CR Meier Journal of clinical pharmacy and therapeutics 44 (6), 924-931, 2019 | 31 | 2019 |
| Community pharmacist-administered COVID-19 vaccinations: A pilot customer survey on satisfaction and motivation to get vaccinated D Stämpfli, A Martinez-De la Torre, E Simi, S Du Pasquier, J Berger, ... Vaccines 9 (11), 1320, 2021 | 20 | 2021 |
| Translation and validation of a tool to assess the impact of clinical pharmacists’ interventions D Stämpfli, P Baumgartner, F Boeni, P Bedouch, ML Lampert, ... International journal of clinical pharmacy 41, 56-64, 2019 | 20 | 2019 |
| Drug-Associated risk tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems CP Kaufmann, D Stämpfli, N Mory, KE Hersberger, ML Lampert BMJ open 8 (3), e016610, 2018 | 17 | 2018 |
| Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross … D Stämpfli, F Boeni, A Gerber, VAD Bättig, R Weidmann, KE Hersberger, ... BMJ open 8 (6), e021284, 2018 | 15 | 2018 |
| Assessment of minor health disorders with decision tree-based triage in community pharmacies D Stämpfli, BA Winkler, SB Vilei, AM Burden Research in Social and Administrative Pharmacy 18 (5), 2867-2873, 2022 | 9 | 2022 |
| Contribution of patient interviews as part of a comprehensive approach to the identification of drug-related problems on geriatric wards D Stämpfli, F Boeni, A Gerber, VAD Bättig, KE Hersberger, ML Lampert Drugs & aging 35, 665-675, 2018 | 9 | 2018 |
| Medication discrepancies in community pharmacies in Switzerland: identification, classification, and their potential clinical and economic impact TL Imfeld-Isenegger, MBT Pham, D Stämpfli, V Albert, E Almanasreh, ... Pharmacy 8 (1), 36, 2020 | 8 | 2020 |
| Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance D Stämpfli, S Weiler, AM Burden European child & adolescent psychiatry 30 (7), 1047-1058, 2021 | 6 | 2021 |
| Community pharmacist-administered seasonal influenza vaccination: a national customer survey D Stämpfli, AMD la Torre, S Du Pasquier, D Stegmann, A Brügger, ... Journal of pharmaceutical policy and practice 13 (1), 57, 2020 | 6 | 2020 |
| Übertragung der niederländischen PCG auf Schweizer Verhältnisse M Trottmann, H Telser, D Stämpfli, KE Hersberger, K Matter, ... Bundesamt für Gesundheit. Bern, 2015 | 6 | 2015 |
| Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data D Stämpfli, S Weiler, CF Weiniger, AM Burden, M Heesen European Journal of Clinical Pharmacology 77, 913-919, 2021 | 5 | 2021 |
| Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot D Stämpfli, TL Imfeld-Isenegger, KE Hersberger, M Messerli BMC Infectious Diseases 23 (1), 384, 2023 | 4 | 2023 |
| Lehrveranstaltung zu interprofessionellen Versorgungsketten in der Schweiz C Schlegel, D Stämpfli, E Kut, G Mang, T Moser, M Useini, J Goldhahn Praxis 110 (1), 26-31, 2022 | 3 | 2022 |
| Psychiatrische Patienten fragen ihren Arzt und Apotheker – wie kann die ambulante Versorgung optimiert werden? P Baumann, M Hahn, SC Roll, D Stämpfli Psychopharmakotherapie 27 (6), 270-7, 2020 | 2 | 2020 |
| Translation and validation of the CLEO tool to assess the potential relevance of pharmacists’ interventions D Stämpfli, P Baumgartner, F Boeni, P Bedouch, ML Lampert Le Pharmacien Hospitalier et Clinicien 52 (1), e16, 2017 | 2 | 2017 |
| External validation of the PAR-Risk Score to assess potentially avoidable hospital readmission risk in internal medicine patients L Higi, A Lisibach, PE Beeler, M Lutters, AL Blanc, AM Burden, D Stämpfli Plos one 16 (11), e0259864, 2021 | 1 | 2021 |
| Drug-related problems: assessments of risk and relevance D Stämpfli University_of_Basel, 2018 | 1 | 2018 |
| Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care ML Faquetti, G Frey, D Stämpfli, S Weiler, AM Burden British Journal of Clinical Pharmacology, 2024 | | 2024 |
